#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16024	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2144	744.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1438	1438	C	936	C	876	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29376	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3603	813.3	0	.	n	.	0	T695C	SNP	695	695	T	1024	1024	C	959	C	885	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29376	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3603	813.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1666	1666	A	1003	A	938	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29376	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3603	813.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2300	2300	C	925	C	859	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29376	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3603	813.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2374	2374	A	875	A	824	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29376	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3603	813.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2926	2926	C	935	C	878	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2226	folP	855	855	100.0	folP.l15.c4.ctg.1	1564	141.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1083	1085	AGC	226;226;228	A;G;C	206;206;207	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6294	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3357	186.9	1	SNP	p	S91F	1	.	.	271	273	TTC	583	585	TTC	215;214;216	T;T;C	201;199;202	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6294	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3357	186.9	1	SNP	p	D95G	1	.	.	283	285	GGC	595	597	GGC	211;207;207	G;G;C	201;197;196	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6294	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3357	186.9	1	SNP	p	G95N	0	.	.	283	285	GGC	595	597	GGC	211;207;207	G;G;C	201;197;196	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1772	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1336	132.2	1	SNP	p	G45D	0	.	.	133	135	GGC	486	488	GGC	226;223;221	G;G;C	210;206;206	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	900	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	911	98.4	0	.	n	.	0	A197.	DEL	197	197	A	542	542	A	221	A	211	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5704	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2965	191.9	1	SNP	p	D86N	0	.	.	256	258	GAC	608	610	GAC	229;233;232	G;A;C	216;217;222	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5704	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2965	191.9	1	SNP	p	S87R	1	.	.	259	261	CGT	611	613	CGT	232;232;232	C;G;T	220;217;217	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5704	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2965	191.9	1	SNP	p	R87I	0	.	.	259	261	CGT	611	613	CGT	232;232;232	C;G;T	220;217;217	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5704	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2965	191.9	1	SNP	p	R87W	0	.	.	259	261	CGT	611	613	CGT	232;232;232	C;G;T	220;217;217	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5704	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2965	191.9	1	SNP	p	S88P	0	.	.	262	264	TCC	614	616	TCC	232;229;229	T;C;C	216;214;213	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4846	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2497	192.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1508	1510	GGC	276;276;275	G,C;G;C	250,1;253;252	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2221	189.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1129	1131	GCA	210;215;217	G;C;A	195;203;205	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2221	189.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1132	1134	ATC	219;220;224	A;T;C	203;205;205	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2221	189.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1144	1146	GTG	227;226;228	G;T;G	208;205;208	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2221	189.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1144	1146	GTG	227;226;228	G;T;G	208;205;208	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2221	189.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1648	1650	ACC	250;249;248	A,G;C;C	231,1;238;240	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2221	189.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1702	1704	GCG	210;213;212	G;C;G	186;175;177	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2221	189.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1702	1704	GCG	210;213;212	G;C;G	186;175;177	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2221	189.8	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1825	1827	AGC	193;190;188	A;G;C	180;173;175	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2221	189.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1834	1836	GGC	182;182;182	G;G;C	168;168;167	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2221	189.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1852	1854	CCG	160;158;160	C,G;C;G	115,4;116;119	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6124	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	2985	204.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1600	1602	CCG	190;194;194	C;C;G	173;178;173	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2600	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1892	137.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	620	620	C	172	C	155	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	97.99	porB1b.l6.c4.ctg.1	1524	188.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	400	402	GAA	265;266;262	G;A;A	250;249;246	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	97.99	porB1b.l6.c4.ctg.1	1524	188.0	0	.	p	.	0	N124S	NONSYN	370	372	AAT	658	660	AGT	236;239;242	A,G;G,A;T	228,1;230,1;233	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	97.99	porB1b.l6.c4.ctg.1	1524	188.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	688	690	GAT	261;262;262	G,A;A;T	239,1;237;240	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	97.99	porB1b.l6.c4.ctg.1	1524	188.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	811	813	TCA	241;242;249	T;C;A	220;222;232	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	97.99	porB1b.l6.c4.ctg.1	1524	188.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	940	942	GTC	223;221;222	G;T;C	207;203;205	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	97.99	porB1b.l6.c4.ctg.1	1524	188.0	0	.	p	.	0	F222S	NONSYN	664	666	TTT	952	954	TCT	228;226;230	T;C;T	216;214;216	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	97.99	porB1b.l6.c4.ctg.1	1524	188.0	0	.	p	.	0	G255_T256del	DEL	763	763	G	1050	1050	T	261	T	247	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	97.99	porB1b.l6.c4.ctg.1	1524	188.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1258	1260	GCA	225;221;224	G;C;A	211;207;208	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	97.99	porB1b.l6.c4.ctg.1	1524	188.0	1	SNP	p	G120K	1	.	.	358	360	AAG	646	648	AAG	243;241;240	A;A;G	226;224;222	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	97.99	porB1b.l6.c4.ctg.1	1524	188.0	1	SNP	p	A121D	1	.	.	361	363	GAC	649	651	GAC	239;238;237	G,A;A;C	218,1;220;222	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	97.99	porB1b.l6.c4.ctg.1	1524	188.0	1	SNP	p	D121N	0	.	.	361	363	GAC	649	651	GAC	239;238;237	G,A;A;C	218,1;220;222	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10704	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4972	214.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1148	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1079	106.1	1	SNP	p	V57M	1	.	.	169	171	ATG	585	587	ATG	254;255;254	A;T;G	237;239;238	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
